Swedish startup Ordo Labs, focused on simplifying bureaucracy for pharmaceutical labs, was accepted into the prestigious Y Combinator accelerator after refining its pitch with support from a KTH team. The founders received positive feedback on the improvements needed.
U.S. and U.K.-based AI infrastructure startup Expanse secured €4.5 million in Seed funding led by Crane Venture Partners, aiming to scale its predictive platform that optimises AI workload compute allocation before execution.
Eterna Regeneratives, a spin‑out from King’s College London, is developing a keratin‑based biomaterial to repair tooth enamel and bone, and raised a $4 million seed round led by Hoxton Ventures and The Venture Collective.
Copenhagen‑based startup Complir secured an $11 million seed round led by General Catalyst to scale its AI‑driven compliance platform for retailers, aiming to automate regulatory checks, cut compliance costs and speed product launches across Europe.
The Danish BioInnovation Institute announced a €9.52 million convertible‑loan programme for 17 early‑stage biotech, healthtech, cleantech and AI startups, aiming to turn university research into commercial companies across Europe.
Lithuanian legaltech startup EnforceShield secured €1.7 million in seed funding led by Vendep Capital, with participation from FIRSTPICK VC, to scale its AI‑powered SaaS platform that automates IP enforcement for online marketplaces and brands.
Swedish startup Halmos Labs aims to speed up the development of new medicines using artificial intelligence and has secured a spot in the renowned US accelerator Y Combinator.
Swiss preventive health startup Aeon raised a seed extension, bringing its total seed funding to over €12 million, and used the round to acquire German blood‑diagnostics platform Aware Health, expanding its AI‑driven whole‑body imaging and biomarker offering across Europe.
Dutch AgTech startup Gravity Gardens raised €2.6 million in a Seed round led by VP Capital, with participation from Brightlands Venture Partners, Graduate Ventures and private investors, to commercialise its dry, chemical‑free seed activation process and build industrial‑scale equipment for broader crop applications.
Swedish spatial‑biology startup Cubase Bio teamed up with Austrian organoid company HeartBeat.bio, receiving about €1 million in Eurostars funding to create the FACTS‑3D project, which combines Cubase Bio’s 3D spatial transcriptomics with HeartBeat.bio’s cardiac organoids for high‑throughput drug discovery targeting myocardial fibrosis.